You are here: Home

ICBP SURVMARK-2 will produce high impact cancer survival, incidence and mortality comparisons as part of the International Cancer Benchmarking Partnership (ICBP). The ICBP is a unique and innovative collaboration that brings together clinicians, policy-makers, researchers, and cancer data experts. It aims to measure international differences in cancer survival, and crucially, to identify factors that might be driving these differences.

The ICBP SURVMARK-2 project was launched in July 2016 and is set to be completed in early 2020.


An ICBP Phase 2 researcher workshop was held on 20 February 2018 in London with attendees from the Programme Board, SurvMark-2 team, Cancer Patient Pathways, Health systems, Clinicians and Programme team - March 2018
As part of the Summer School on Modern Methods in Biostatistics and Epidemiology, Paul Dickman and Paul Lambert will present an intensive 1-week course on the principles, methods and application of statistical methods in population-based cancer survival analysis. Further details are available here - December 2017
A SURVMARK-2 Meeting was organized during the 39th Annual Conference of the International Association of Cancer Registries on 18 October 2017 with SURVMARK-2 colleagues and partners present during the conference.
Call for expertise transfer fellowship applications will soon be launched
Kick-off meeting of the executive group held in London on 27/28 March 2017. View photo
SURVMARK-2 call for data launched in July 2016 – 20 jurisdictions from 6 countries participating